In 2013, the Sustainable Predictive Oncology Therapeutics and Diagnostics (SPOT/Dx) working group committed to developing a new approach to assess laboratory test validation and performance. Consequently, the Diagnostic Quality Assurance Pilot was…
Precision medicine and diagnostics / Healthcare
The rise to prominence of environmental, social, and governance issues (ESG) has caused boards to assess how best to oversee these matters. Investors and other stakeholders are calling for both concrete actions and heightened disclosures on a range…
Board and committee effectiveness, Board risk oversight, Investor perspectives on public companies
On January 28, 2021, Insurance Governance Leadership Network (IGLN) participants, including non-executive directors and other senior insurance leaders, were joined by EY’s insurance leaders to discuss priorities for insurance boards and management…
Governance, Regulation and supervision, Risk management and oversight / Insurance and Asset Management
A new frontier in cancer screening is leveraging liquid-based detection, which look for signals of cancer in blood, urine, or stool samples, to create multi- rather than single-cancer screens. For those organizations focused on advancing multicancer…
Precision medicine and diagnostics, Health system readiness / Healthcare
On January 21, 2021, Bank Governance Leadership Network (BGLN) participants, including non-executive directors and other senior banking leaders, were joined by EY’s banking and capital markets leaders to discuss priorities for bank boards and…
Governance, Regulation and supervision, Risk management and oversight / Banking
The COVID-19 pandemic accelerated technology transformations in large financial institutions, as employees moved to remote work and as customers shifted to digital channels. Customers have come to expect uninterrupted, personalized digital products…
Innovation and technology, Risk management and oversight, Financial Strategy / Banking, Innovation and technology, Risk management and oversight, Financial Strategy / Insurance and Asset Management
The COVID-19 pandemic caused massive personal and economic upheaval across the globe. It led to unprecedented actions from governments and central banks to support businesses and individuals, and it accelerated some trends toward deglobalization. As…
Governance, Innovation and technology, Regulation and supervision / Banking, Governance, Innovation and technology, Regulation and supervision / Insurance and Asset Management
At the beginning of 2020, senior leaders’ conversation on environmental, social, and governance (ESG) issues focused almost exclusively on climate change. As global leaders assembled for the World Economic Forum’s annual meeting in January 2020,…
Governance, Risk management and oversight, Financial Strategy / Banking, Governance, Risk management and oversight, Financial Strategy / Insurance and Asset Management
Despite corporate culture’s clear impact on business results and long term value, few boards bring the same rigor to their oversight of culture that they apply to strategy, operations, or CEO succession. During companion meetings on December 1 and…
Board and committee effectiveness, Boards and General Management, Board risk oversight
Recent controversies in the United Kingdom have brought accounting and auditing into the limelight, prompting calls for greater scrutiny and for deep changes in the way auditing takes place. Reviews of the profession have assessed its market…
Accounting and financial reporting, Corporate and board regulatory matters, Working with the internal and external auditor